The impact of Covid-19 on a group of innovation-based companies – a report of our survey findings

Advanced Oxford has been collecting insights from Oxfordshire-based innovation/R&D companies since the start of the lock-down period via a short on-line survey (https://www.surveymonkey.co.uk/r/D73XTBS).  The survey poses a set of questions across a number of business issues, focusing on the impact of the Covid-19 virus and the associated changes in working practices.  The Covid-19 pandemic has created unprecedented business conditions, with all sectors of the economy being significantly impacted by the lock-down, social distancing, the health crisis and its associated social and economic impacts.

Government is working to respond to these changes and this analysis of results provides insight and evidence from a group of businesses around key issues including investment, cash-flow and the workforce.  Advanced Oxford is sharing the results and analysis with policy makers at the local, regional and national level.

Read our analysis: Covid 19 company effects – report of findings to 14 April 2020 final

HIGHLIGHTS

  • Significant concerns relate to investment and cash-flow.
  • While 87% of the companies responding stated that they were expecting to grow, prior to the crisis, only 37% companies now expect to see growth in the next year.
  • Commercial companies have seen negative impacts on sales, ranging from 20 – 50%, where the impact was quantified.
  • Over a third of companies are experiencing significant supply chain issues and 80% of companies are experiencing delays or are stalling their research and development activity.

Recent news

Benedicts joins CBRE as joint agents for Milton Park

Benedicts joins CBRE as joint agents for Milton Park

Milton Park, the UK’s largest single ownership innovation community, has appointed Benedicts to join CBRE as joint leasing agents for the 2.8 million sq ft Park. Milton Park welcomed over 40 new occupiers in 2025 and is now home to more than 280 innovative companies....

read more
Launch of the BioEscalator Annual Review – 2024/25

Launch of the BioEscalator Annual Review – 2024/25

People and partnerships driving better patient health The BioEscalator is the University of Oxford’s thriving incubator for fast-growing biomedical companies. In 2024/25 it worked with people and organisations across the local and global innovation ecosystem and it’s...

read more
Loading...